Neo Ivy Capital Management reduced its holdings in Xylem Inc. (NYSE:XYL - Free Report) by 56.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,105 shares of the industrial products company's stock after selling 4,057 shares during the quarter. Neo Ivy Capital Management's holdings in Xylem were worth $360,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Lee Danner & Bass Inc. purchased a new position in Xylem during the fourth quarter valued at $30,000. Rialto Wealth Management LLC purchased a new stake in Xylem during the fourth quarter valued at $31,000. Heck Capital Advisors LLC purchased a new stake in Xylem during the fourth quarter valued at $36,000. Pathway Financial Advisers LLC increased its position in Xylem by 122.4% during the fourth quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock valued at $37,000 after acquiring an additional 175 shares during the last quarter. Finally, SRS Capital Advisors Inc. increased its position in Xylem by 69.5% during the fourth quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock valued at $37,000 after acquiring an additional 130 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.
Xylem Price Performance
Shares of Xylem stock traded down $0.20 on Thursday, hitting $125.05. 191,878 shares of the company were exchanged, compared to its average volume of 1,407,835. The stock has a market capitalization of $30.43 billion, a price-to-earnings ratio of 34.15, a price-to-earnings-growth ratio of 2.33 and a beta of 1.10. The company has a 50-day moving average price of $117.90 and a 200 day moving average price of $121.55. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $143.50. The company has a quick ratio of 1.33, a current ratio of 1.76 and a debt-to-equity ratio of 0.19.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.95 by $0.08. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm had revenue of $2.07 billion for the quarter, compared to analyst estimates of $2.04 billion. During the same quarter in the previous year, the company earned $0.90 EPS. The business's revenue for the quarter was up 1.8% compared to the same quarter last year. As a group, sell-side analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th will be issued a $0.40 dividend. The ex-dividend date is Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.28%. Xylem's payout ratio is 43.01%.
Analyst Ratings Changes
A number of analysts recently commented on XYL shares. Robert W. Baird reduced their price objective on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research report on Wednesday, April 30th. Stifel Nicolaus upped their price objective on Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a research report on Wednesday, April 30th. Citigroup cut their price target on Xylem from $152.00 to $134.00 and set a "buy" rating for the company in a report on Monday, April 14th. Raymond James raised Xylem to a "hold" rating in a report on Thursday, May 15th. Finally, Royal Bank of Canada boosted their price target on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, Xylem currently has a consensus rating of "Moderate Buy" and a consensus target price of $146.88.
Get Our Latest Report on XYL
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.